Skip to content

Effect of epidural anesthesia/analgesia on cancer recurrence and metastasis after lung cancer surgery: a single-center, randomized controlled trial

Effect of epidural anesthesia/analgesia on cancer recurrence and metastasis after lung cancer surgery: a single-center, randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-14004136
Enrollment
Unknown
Registered
2014-01-02
Start date
2015-05-25
Completion date
Unknown
Last updated
2020-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-small cell lung cancer

Interventions

Sponsors

Peking University First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. aged between 18 and 80 years; 2. clinically diagnosed as primary non-small cell lung cancer (stage IA-IIIA) and scheduled to undergo radical surgery; 3. agreed to receive patient-controlled analgesia after surgery.

Exclusion criteria

Exclusion criteria: 1. Distant metastasis, malignant tumor in other organs or chemo-/radio- or other anti-cancer therapy before surgery; 2. comorbid with autoimmune diseases, or glucocorticoid/immunosuppressant therapy within 1 year; 3. previous history of schizophrenia, epilepsy or Parkinson disease, or unable to complete preoperative assessment due to severe dementia, language barrier, or end-stage disease, or other disorders related to the development of tumors, i.e. depression or other psychological disorders; 4. history of anesthesia (including general anesthesia and epidural anesthesia) and/or surgery within 1 year; 5. contraindications to epidural anesthesia, including spinal deformity, coagulation dysfunction, local infection, history of spinal trauma/surgery; 6. severe hepatic insufficiency (Child-Pugh classification C), kidney insufficiency (serum creatinine >442 umol/L or receiving renal replacement therapy), or American Society of Anesthesiologist (ASA) physical status classification >=IV; 7. allergic to any medication (including local anesthetic and opioids) during the study.

Design outcomes

Primary

MeasureTime frame
recurrence-free survival;

Secondary

MeasureTime frame
Rate of intensive care unit (ICU) admission after surgery;Incidence of postoperative complications during hospital stay;Length of chest tube drainage after surgery;Length of stay in hospital after surgery;All-cause in-hospital mortality after surgery;Activety engagement among 1-year survivors;Cancer-specific survival;Overall survival;

Countries

China

Contacts

Public ContactWang Dongxin

Peking University First Hospital

wangdongxin@hotmail.com+86 13910731903

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 7, 2026